SPIKEVAX by Catalent Indiana, LLC

SPIKEVAX by

Drug Labeling and Warnings

SPIKEVAX by is a Other medication manufactured, distributed, or labeled by Catalent Indiana, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPIKEVAX- covid-19 vaccine, mrna injection, suspension 
Catalent Indiana, LLC

----------

256-100-000 Carton256-100-000 Case.jpg

SPIKEVAX 
covid-19 vaccine, mrna injection, suspension
Product Information
Product TypeVACCINEItem Code (Source)NDC: 61434-043
Route of AdministrationINTRAMUSCULAR
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ELASOMERAN (UNII: EPK39PL4R4) (ELASOMERAN - UNII:EPK39PL4R4) ELASOMERAN0.1 mg  in 0.5 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 61434-043-02120 in 1 CASE
1NDC: 61434-043-0110 in 1 CARTON
1NDC: 61434-043-005.5 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
BLABLA12575204/01/2022
Labeler - Catalent Indiana, LLC (172209277)
Registrant - ModernaTX, Inc. (116912313)

Revised: 5/2022
 

Trademark Results [SPIKEVAX]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SPIKEVAX
SPIKEVAX
97037862 not registered Live/Pending
ModernaTx, Inc.
2021-09-21
SPIKEVAX
SPIKEVAX
90247367 not registered Live/Pending
ModernaTx, Inc.
2020-10-11

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.